FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, gestures during an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland, May 15, 2018. REUTERS/Arnd Wiegmann/File Photo